Pallavi Madhiraju
25980 posts
Pallavi has been a news reporter since 2004 writing for several websites, covering various subjects.
Universal Studios enters Saudi Arabia: Could this be Comcast’s biggest international bet yet?
Universal Studios may build a theme park in Saudi Arabia. Find out what this means for Comcast, Saudi Vision 2030, and global entertainment strategy.
December 21, 2025
NS-25 flight by Blue Origin sets inclusion milestone with wheelchair user in crew
Blue Origin’s latest launch included the first wheelchair user in space. Learn how this changes the game for inclusive space travel and aerospace strategy.
December 21, 2025
Aldi’s U.S. grocery expansion is forcing a rethink at Walmart and The Kroger Company
Aldi’s U.S. expansion is challenging Walmart and The Kroger Company with a no-frills, private-label model. Find out what this shift means for retail.
December 21, 2025
Hypercharge (HC, HCNWF) appoints Chris Koch as COO, signs Peterson Capital for IR push
Hypercharge names Chris Koch as COO and signs Peterson Capital to boost IR efforts. Find out how this reshapes operations and market positioning in 2026.
December 21, 2025
FDA approves Cytokinetics’ MYQORZO for obstructive HCM after SEQUOIA-HCM trial success
FDA approves Cytokinetics’ aficamten for obstructive HCM. Find out what this means for cardiologists, patients, and rival Camzyos as MYQORZO prepares to launch.
December 21, 2025
IIFL Finance (NSE: IIFL) strengthens governance with appointment of ex-RBI Deputy Governor B. P. Kanungo as Chair
IIFL Finance appoints ex-RBI Deputy Governor B. P. Kanungo as Chairperson. Find out how this move could reshape governance and growth strategy.
December 21, 2025
Why Bristol Myers Squibb is giving away Eliquis to Medicaid and what it signals for U.S. drug pricing next
Bristol Myers Squibb will offer Eliquis free to Medicaid under a U.S. pricing deal. Find out what it means for drug pricing, investors, and patients.
December 20, 2025
Hansa Biopharma targets Q3 2026 approval for imlifidase with Priority Review request
Hansa Biopharma submits imlifidase BLA to the FDA, aiming to transform access to kidney transplants for highly sensitized patients. Read more on what’s next.
December 20, 2025
Can Shanghai Electric’s 625MW Iraq project reset the energy equation in the Middle East?
Shanghai Electric’s 625MW Iraq project promises 50% more power without more fuel. Find out how this could change energy strategy in the Middle East.
December 20, 2025
Why Energy Transfer just pulled the plug on Lake Charles LNG despite regulatory greenlights
Energy Transfer has canceled development of its Lake Charles LNG project, reallocating capital to faster-growth pipeline systems. Find out what this shift means.
December 20, 2025